Where Will Salesforce Stock Be in 5 Years?
Salesforce (NYSE: CRM) just turned in a quarter that, on…
Sell
46
EYPT Quote, Financials, Valuation and Earnings
Last price:
$7.23
Seasonality move
:
-2.36%
Day range:
$6.86 - $7.58
52-week range:
$3.91 - $13.99
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
7.82x
P/B ratio:
1.67x
Volume:
2.1M
Avg. volume:
798.5K
1-year change:
-32.65%
Market cap:
$498.2M
Revenue:
$43.3M
EPS (TTM):
-$2.41
EYPT Analysts' Consensus Rating
The 9 analysts providing 12-month price projections for EyePoint Pharmaceuticals shares anticipate an average target of $32.00, ranging from a low estimate of $18.00 to a high estimate of $68.00. This average target implies a growth of 341.99% compared to the current stock price of $7.24.
Consensus Price Target
$32.00
Highest Price Target
$68.00
Lowest Price Target
$18.00
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Analyst Ratings
| 6M Ago | 1M Ago | Current | |
|---|---|---|---|
| Buy | 8 | 9 | 9 |
| Hold | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 |
| Consensus | Buy | Buy | Buy |
EYPT Recommendation Trends
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
2 Ultra Safe Dividend Stocks to Buy Now
Historically, blue-chip dividend stocks have been good choices for periods…
Where Will Asana Stock Be in 5 Years?
Asana stock hasn’t given many investors on Wall Street any…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
65
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Sell
31
REGN alert for May 31
Regeneron Pharmaceuticals [REGN] is down 19.04% over the past day.
Buy
55
RGC alert for May 31
Regencell Bioscience Holdings [RGC] is up 16.13% over the past day.
Sell
42
AMBA alert for May 31
Ambarella [AMBA] is down 15.13% over the past day.
